Modulation of the unfolded protein response pathway as an antiviral approach in airway epithelial cells.
Antiviral Agents
/ pharmacology
Bronchi
/ cytology
Case-Control Studies
Cells, Cultured
Child
Cystic Fibrosis
/ complications
Endoplasmic Reticulum Chaperone BiP
Endoplasmic Reticulum Stress
/ drug effects
Epithelial Cells
/ drug effects
Humans
Respiratory Mucosa
/ cytology
Rhinovirus
/ drug effects
Signal Transduction
Unfolded Protein Response
Virus Replication
/ drug effects
Cystic fibrosis
Endoplasmic reticulum stress
Rhinovirus
Unfolded protein response
Journal
Antiviral research
ISSN: 1872-9096
Titre abrégé: Antiviral Res
Pays: Netherlands
ID NLM: 8109699
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
10
08
2018
revised:
07
11
2018
accepted:
10
12
2018
pubmed:
15
12
2018
medline:
11
2
2020
entrez:
15
12
2018
Statut:
ppublish
Résumé
Rhinovirus (RV) infection is a major cause of cystic fibrosis (CF) lung morbidity with limited therapeutic options. Various diseases involving chronic inflammatory response and infection are associated with endoplasmic reticulum (ER) stress and subsequent activation of the unfolded protein response (UPR), an adaptive response to maintain cellular homeostasis. Recent evidence suggests impaired ER stress response in CF airway epithelial cells, this might be a reason for recurrent viral infection in CF. Therefore, assuming that ER stress inducing drugs have antiviral properties, we evaluated the activation of the UPR by selected ER stress inducers as an approach to control virus replication in the CF bronchial epithelium. We assessed the levels of UPR markers, namely the glucose-regulated protein 78 (Grp78) and the C/EBP homologous protein (CHOP), in primary CF and control bronchial epithelial cells and in a CF and control bronchial epithelial cell line before and after infection with RV. The cells were also pretreated with ER stress-inducing drugs and RV replication and shedding was measured by quantitative RT-PCR and by a TCID We observed a significantly impaired induction of Grp78 and CHOP in CF compare to control cells following RV infection. The ER stress response could be significantly induced in CF cells by pharmacological ER stress inducers Brefeldin A, Tunicamycin, and Thapsigargin. The chemical induction of the UPR pathway prior to RV infection of CF and control cells reduced viral replication and shedding by up to two orders of magnitude and protected cells from RV-induced cell death. RV infection causes an impaired activation of the UPR in CF cells. Rescue of the ER stress response by chemical ER stress inducers reduced significantly RV replication in CF cells. Thus, pharmacological modulation of the UPR might represent a strategy to control respiratory virus replication in the CF bronchial epithelium.
Identifiants
pubmed: 30550797
pii: S0166-3542(18)30496-0
doi: 10.1016/j.antiviral.2018.12.007
pii:
doi:
Substances chimiques
Antiviral Agents
0
Endoplasmic Reticulum Chaperone BiP
0
HSPA5 protein, human
0
Types de publication
Evaluation Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
44-50Informations de copyright
Copyright © 2018 Elsevier B.V. All rights reserved.